1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 11-dehydro-thromboxane b2 in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (11-dehydro-thromboxane b2) | Trials (11-dehydro-thromboxane b2) | Recent Studies (post-2010) (11-dehydro-thromboxane b2) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 380 | 89 | 89 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miura, K; Yamamoto, K; Yamanaka, S; Yukimura, T | 1 |
| Deev, AD; Dobrovol'skiĭ, AB; Katkova, OV; Laguta, PS; Panchenko, EP; Titaeva, EV | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 11-dehydro-thromboxane b2
| Article | Year |
|---|---|
[Aspirin resistance in patients with stable ischemic heart disease].
Topics: Aged; Aspirin; Coronary Angiography; Drug Monitoring; Drug Resistance; Echocardiography, Transesophageal; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Activating Factor; Risk Factors; Severity of Illness Index; Thromboxane B2; Treatment Outcome | 2010 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 11-dehydro-thromboxane b2
| Article | Year |
|---|---|
11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs.
Topics: Animals; Dogs; Female; Lung; Male; Platelet Activating Factor; Reproducibility of Results; Thromboxane A2; Thromboxane B2; Vascular Resistance | 1993 |